5,151 Shares in Encompass Health Corporation $EHC Purchased by Inceptionr LLC

Inceptionr LLC purchased a new stake in shares of Encompass Health Corporation (NYSE:EHC) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 5,151 shares of the company’s stock, valued at approximately $497,000.

A number of other hedge funds and other institutional investors have also modified their holdings of EHC. WPG Advisers LLC boosted its stake in shares of Encompass Health by 73.3% in the 4th quarter. WPG Advisers LLC now owns 324 shares of the company’s stock valued at $34,000 after purchasing an additional 137 shares during the last quarter. Flagship Harbor Advisors LLC acquired a new position in Encompass Health in the fourth quarter valued at approximately $37,000. Assetmark Inc. lifted its holdings in Encompass Health by 89.6% in the first quarter. Assetmark Inc. now owns 455 shares of the company’s stock valued at $44,000 after buying an additional 215 shares during the period. Caitong International Asset Management Co. Ltd boosted its stake in Encompass Health by 36,200.0% in the third quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock valued at $46,000 after acquiring an additional 362 shares during the last quarter. Finally, Aster Capital Management DIFC Ltd acquired a new stake in Encompass Health during the 4th quarter worth $55,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. Leerink Partners set a $152.00 target price on Encompass Health in a report on Friday, May 22nd. TD Cowen began coverage on shares of Encompass Health in a report on Thursday, May 28th. They set a “buy” rating and a $125.00 price objective for the company. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Weiss Ratings cut shares of Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, June 26th. Finally, Barclays dropped their price objective on Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a research note on Tuesday, May 5th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $143.86.

Encompass Health Stock Performance

Shares of EHC stock opened at $112.66 on Friday. Encompass Health Corporation has a 12 month low of $92.77 and a 12 month high of $127.99. The company’s fifty day simple moving average is $104.97 and its 200-day simple moving average is $103.80. The firm has a market cap of $11.18 billion, a PE ratio of 18.81, a P/E/G ratio of 2.46 and a beta of 0.74. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.51 by $0.09. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The firm had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.57 billion. During the same period last year, the company earned $1.37 earnings per share. The business’s revenue was up 9.0% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Equities research analysts expect that Encompass Health Corporation will post 5.96 EPS for the current fiscal year.

Encompass Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be issued a $0.21 dividend. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $0.84 annualized dividend and a yield of 0.7%. This is an increase from Encompass Health’s previous quarterly dividend of $0.19. Encompass Health’s payout ratio is currently 12.69%.

Insider Transactions at Encompass Health

In other news, EVP Patrick William Tuer sold 682 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $104.56, for a total value of $71,309.92. Following the transaction, the executive vice president owned 24,755 shares of the company’s stock, valued at approximately $2,588,382.80. This represents a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.80% of the stock is owned by company insiders.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.